• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Testicular Cancer Pipeline Insights, 2017 - Research and Markets

    Testicular Cancer Pipeline Insights, 2017 - Research and Markets

  2. Colorectal Cancer - Pipeline Review, H2 2016 - Therapeutics Assessment by Drug Target, MoA, RoA & Molecule Type - Research and Markets

    Colorectal Cancer - Pipeline Review, H2 2016 - Therapeutics Assessment by Drug Target, MoA, RoA & Molecule Type - Research and Markets

  3. ImmunoGen Announces Webcasts of Presentations at Upcoming Investor Conferences

    ImmunoGen Announces Webcasts of Presentations at Upcoming Investor Conferences

  4. Exelixis and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan

    Exelixis and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan

©2017 Morningstar Advisor. All right reserved.